Eric L. Stangeland

Preclinical to Clinical Translation of CNS Transporter Occupancy of TD-9855, a Novel Norepinephrine and Serotonin Reuptake Inhibitor

W. Williams, R. Carson, J. Gallezot, 2015, The international journal of neuropsychopharmacology.

Preclinical efficacy of THRX-200495, a dual pharmacology muscarinic receptor antagonist and β(2)-adrenoceptor agonist (MABA).

M. Mammen, W. Martin, S. Hegde, 2012, Pulmonary pharmacology & therapeutics.

Total synthesis of caerulomycin C via the halogen dance reaction.

T. Sammakia, E. Stangeland, M. Whitcomb, 2002, Organic letters.

A novel class of 3-(phenoxy-phenyl-methyl)-pyrrolidines as potent and balanced norepinephrine and serotonin reuptake inhibitors: synthesis and structure-activity relationships.

W. Martin, L. J. Van Orden, R. Chang, 2013, Bioorganic & medicinal chemistry letters.

Transfer Hydrogenation with Ruthenium Complexes of Chiral (Phosphinoferrocenyl)oxazolines

T. Sammakia, E. Stangeland, Eric L. Stangeland, 1997 .

Muscarinic receptor subtypes and signalling involved in the attenuation of isoprenaline-induced rat urinary bladder relaxation

M. Mammen, M. Michel, J. Aiyar, 2011, Naunyn-Schmiedeberg's Archives of Pharmacology.

Use of thiazoles in the halogen dance reaction: application to the total synthesis of WS75624 B.

T. Sammakia, E. Stangeland, Eric L. Stangeland, 2004, The Journal of organic chemistry.